Login to Your Account

Abbvie withdraws suit as data transparency legislation gets EU vote

By Nuala Moran
Staff Writer

Thursday, April 3, 2014

Abbvie Inc. has withdrawn the legal case it took out to prevent the EMA from publishing the clinical study reports relating to its anti-TNF alpha drug, Humira, after the agency accepted a new set of redacted documents and agreed with the company’s rationale for removing certain commercially confidential information from the reports at the center of the litigation.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription